Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a medicine that is used to treat prostate cancer in adults. Pluvicto may be used to treat PSMA-positive prostate cancer that has spread to other ...
Other than skin cancer, prostate cancer is the most common type of cancer in men in the U.S. In 2026, almost 330,000 people will be diagnosed with prostate cancer, the National Cancer Institute ...
A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay disease progression in men with specific DNA repair gene mutations. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results